← Leaderboards
Kathleen L Collins
University Of Michigan At Ann Arbor
$36,100,709
Attributed
$44,028,928
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,028,928 · 20
By mechanism
R01$28,422,050 · 8
T32$9,310,377 · 2
R33$2,183,146 · 2
R21$1,650,371 · 4
R56$1,453,559 · 3
R61$1,009,425 · 1
Top collaborators
- Charles A Parkos8 shared
- David H Sherman8 shared
- Joshua Welch8 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sylvie Garneau-Tsodikova$5,849,312
- Oren Shalom Rom$3,844,260
- Michael Edmund Watson$496,365
- David Jay Lubow$34,520
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionT-LymphocyteViralHiv-1AffectHiv InfectionsIn VivoGene ExpressionPathway InteractionsVirusImmune ResponseMolecularAntiretroviral TherapyLeadCell TypeImmuneInsightTraffickingViral GenesUnited StatesBaseMediatingGenome
Grant awards (89)
Next-Generation CMA/CMB Derivatives as Targeted Inhibitors of HIV Nef$3,110,884
R01 · FY2025 · AI · contact PI
Michigan Medical Scientist Training Program 2025-2030$1,574,716
T32 · FY2025 · GM · contact PI
Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis$702,514
R33 · FY2025 · DA · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$658,263
R01 · FY2025 · DK
Michigan Medical Scientist Training Program$1,618,270
T32 · FY2024 · GM · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$686,638
R01 · FY2024 · DK
Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation$677,479
R01 · FY2024 · AI · contact PI
Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis$497,860
R61 · FY2024 · DA · contact PI
Michigan Medical Scientist Training Program$59,936
T32 · FY2024 · GM · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$21,136
R01 · FY2024 · DK
Michigan Medical Scientist Training Program$1,567,445
T32 · FY2023 · GM · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$730,848
R01 · FY2023 · DK
Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation$693,617
R01 · FY2023 · AI · contact PI
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$686,433
R01 · FY2023 · AI
Cellular Reservoirs of HIV$601,675
R01 · FY2023 · AI · contact PI
Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis$511,565
R61 · FY2023 · DA · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$127,078
R01 · FY2023 · DK
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$80,346
R01 · FY2023 · AI
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$80,346
R01 · FY2023 · AI
Michigan Medical Scientist Training Program$58,054
T32 · FY2023 · GM · contact PI
Cellular Reservoirs of HIV$35,696
R01 · FY2023 · AI · contact PI
Michigan Medical Scientist Training Program$1,539,976
T32 · FY2022 · GM · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$748,281
R01 · FY2022 · DK
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$700,841
R01 · FY2022 · AI
Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation$657,841
R01 · FY2022 · AI · contact PI
Cellular Reservoirs of HIV$656,609
R01 · FY2022 · AI · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$105,689
R01 · FY2022 · DK
Cellular Reservoirs of HIV$77,632
R01 · FY2022 · AI · contact PI
Michigan Medical Scientist Training Program$57,036
T32 · FY2022 · GM · contact PI
Cellular Reservoirs of HIV$41,936
R01 · FY2022 · AI · contact PI
Michigan Medical Scientist Training Program$1,397,835
T32 · FY2021 · GM · contact PI
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction$764,673
R01 · FY2021 · DK
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$698,581
R01 · FY2021 · AI
Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation$657,841
R01 · FY2021 · AI · contact PI
Cellular Reservoirs of HIV$656,609
R01 · FY2021 · AI · contact PI
Michigan Medical Scientist Training Program$53,763
T32 · FY2021 · GM · contact PI
Michigan Medical Scientist Training Program$1,383,346
T32 · FY2020 · GM · contact PI
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$844,572
R01 · FY2020 · AI
Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation$673,441
R01 · FY2020 · AI · contact PI
Cellular Reservoirs of HIV$656,609
R01 · FY2020 · AI · contact PI
Development of natural product inhibitors of Nef for clearance of HIV reservoirs$739,671
R01 · FY2019 · AI
Cellular Reservoirs of HIV$665,609
R01 · FY2019 · AI · contact PI
HIV evasion of the innate immune response$188,354
R21 · FY2019 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$526,780
R33 · FY2018 · AI · contact PI
HIV evasion of the innate immune response$227,086
R21 · FY2018 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$36,278
R33 · FY2018 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$458,787
R33 · FY2017 · AI · contact PI
Molecular Mechanisms of the Innate Immune Response in HIV-Infected Macrophages$381,135
R56 · FY2017 · AI · contact PI
HIV Infection of Hematopoietic Progenitor Cells$541,282
R01 · FY2016 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$458,787
R33 · FY2016 · AI · contact PI
HIV Infection of Hematopoietic Progenitor Cells$579,863
R01 · FY2015 · AI · contact PI
Molecular Mechanisms of HIV Innate Immune Evasion$334,300
R56 · FY2015 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$236,823
R21 · FY2015 · AI · contact PI
HIV Infection of Hematopoietic Progenitor Cells$579,304
R01 · FY2014 · AI · contact PI
Development of Nef antagonists to enhance CTL clearance of HIV reservoirs$186,912
R21 · FY2014 · AI · contact PI
HIV Infection of Hematopoietic Progenitor Cells$546,206
R01 · FY2013 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$357,499
R56 · FY2013 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$355,851
R01 · FY2013 · AI · contact PI
HIV Infection of Hematopoietic Progenitor Cells$608,224
R01 · FY2012 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$378,564
R01 · FY2012 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$378,564
R01 · FY2011 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$365,362
R01 · FY2011 · AI · contact PI
HIV infection of bone marrow progenitor cells$153,945
R21 · FY2011 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$395,129
R01 · FY2010 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$376,493
R01 · FY2010 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$358,131
R01 · FY2010 · AI · contact PI
Development of Nef Inhibitors$264,753
R21 · FY2010 · AI · contact PI
HIV infection of bone marrow progenitor cells$240,945
R21 · FY2010 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$51,579
R01 · FY2010 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$457,435
R01 · FY2009 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$374,689
R01 · FY2009 · AI · contact PI
Development of Nef Inhibitors$151,553
R21 · FY2009 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$25,839
R01 · FY2009 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$372,780
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$316,183
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$54,197
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$322,306
R01 · FY2007 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$253,334
R01 · FY2007 · AI · contact PI
Molecular Mechanisms of HIV Disease Pathogenesis$380,625
R56 · FY2006 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$332,473
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of HIV's Immune Evasion$342,130
R01 · FY2005 · AI
Molecular Mechanisms of HIV Disease Pathogenesis$340,328
R01 · FY2005 · AI
Molecular Mechanisms of HIV's Immune Evasion$342,130
R01 · FY2004 · AI
Molecular Mechanisms of HIV Disease Pathogenesis$340,328
R01 · FY2004 · AI
Molecular Mechanisms of HIV Disease Pathogenesis$337,790
R01 · FY2003 · AI
MOLECULAR MECHANISMS OF HIV IMMUNE EVASION$296,759
R01 · FY2003 · AI
MOLECULAR MECHANISMS OF HIV IMMUNE EVASION$296,759
R01 · FY2002 · AI
MOLECULAR MECHANISMS OF HIV IMMUNE EVASION$297,708
R01 · FY2001 · AI
MOLECULAR MECHANISMS OF HIV IMMUNE EVASION$267,456
R01 · FY2000 · AI